{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:01:03Z","timestamp":1787317263176,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NTNU Norwegian University of Science and Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>It is known that pregnancy affects disease activity in Rheumatoid arthritis (RA), but earlier studies have shown conflicting results regarding the degree of change and the role of antibodies. Few studies have been conducted on patients with use of Tumor Necrosis Factor-\u03b1 Inhibitors (TNFi) throughout pregnancy. The aims of this study were to investigate disease activity in women with RA from preconception to 12\u2009months postpartum and assess the influence of anti-cyclic citrullinated protein antibodies (ACPA), rheumatoid factor (RF), erosive disease, and time trends.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective multicenter cohort study used data from the Norwegian RevNatus registry (2007\u20132024). Women with RA were followed before pregnancy, each trimester, and until 12\u2009months postpartum. We assessed disease activity using Disease Activity Score in 28 joints with C-Reactive Protein (DAS28(3)CRP). Linear mixed models were used to evaluate changes over time and interactions with ACPA, RF and erosions, and we divided pregnancies into three groups by year of delivery. Flares were defined as a change of DAS28(3)CRP\u2009&gt;\u20091.2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 598 pregnancies in 475 women were included. The estimated mean DAS28(3)CRP decreased from 2.39 in 2\n                      <jats:sup>nd<\/jats:sup>\n                      to 2.27 in 3\n                      <jats:sup>rd<\/jats:sup>\n                      trimester (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003) and increased significantly to 2.52 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) at 6\u2009weeks postpartum with 16% experiencing flares. The proportion improving during pregnancy was 11%, but 49% in those with DAS28(3)CRP\u2009&gt;\u20093.2 in 1\n                      <jats:sup>st<\/jats:sup>\n                      trimester. Seropositive women had more fluctuations during pregnancy and higher postpartum activity; seronegative women showed minimal variation. Erosive disease did not have a significant effect. Disease activity before, during and after pregnancy decreased in later years of delivery, corresponding to increased use of TNFi.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Most women with RA maintained remission during pregnancy, but postpartum flares still occurred. Improvement was seen in pregnancies with initial high disease activity, but not in women with well managed disease. Seropositive women experienced higher disease activity and larger increase in DAS28(3)CRP postpartum. Women with pregnancies after 2020 had consistently lower disease activity compared to those who were pregnant in 2007\u20132019, coinciding with broader TNFi use during pregnancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41927-026-00663-7","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:55:07Z","timestamp":1780462507000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The biologic era and pregnancy in rheumatoid arthritis: a prospective multicenter study from the Norwegian RevNatus registry"],"prefix":"10.1186","volume":"10","author":[{"given":"Ingunn","family":"Sagberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina G\u00f8testam","family":"Skorpen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stian","family":"Lydersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingvild Birgitte","family":"Refsn\u00e6s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Birgitte","family":"Aga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente","family":"Jakobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hege Suorza","family":"Svean Koksvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Wallenius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"663_CR1","unstructured":"The ameliorating effect of pregnancy on chronic atrophic (infectious rheumatoid) arthritis, fibrositis, and intermittent hydrarthrosis: Hench PS. Classic papers in rheumatology. CRC Press; 2001."},{"issue":"3","key":"663_CR2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3899\/jrheum.180226","volume":"46","author":"H Jethwa","year":"2019","unstructured":"Jethwa H, Lam S, Smith C, Giles I. Does rheumatoid arthritis really improve during pregnancy? A systematic review and metaanalysis. J Rheumatol. 2019 Mar;46(3):245\u201350. https:\/\/doi.org\/10.3899\/jrheum.180226 PubMed PMID: 30385703.","journal-title":"J Rheumatol"},{"issue":"7","key":"663_CR3","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/annrheumdis-2020-219547","volume":"80","author":"HT Smeele","year":"2021","unstructured":"Smeele HT, R\u00f6der E, Wintjes HM, Kranenburg-van Koppen LJ, Hazes JM, Dolhain RJ. Modern treatment approach results in low disease activity in 90% of pregnant rheumatoid arthritis patients: the PreCARA study. Ann Rheumatic Dis. 2021 Jul;80(7):859\u201364. https:\/\/doi.org\/10.1136\/annrheumdis-2020-219547 PubMed PMID: 33568387; PubMed Central PMCID: PMC8237196.","journal-title":"Ann Rheumatic Dis"},{"issue":"1","key":"663_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s41927-025-00479-x","volume":"9","author":"M Couderc","year":"2025","unstructured":"Couderc M, Lambert C, Hamroun S, Gallot D, Costedoat-Chalumeau N, Gossec L, et al. Disease activity during pregnancy in patients with rheumatoid arthritis or spondyloarthritis: results from the multicentre prospective GR2 study. BMC Rheumatol. 2025 Mar 11;9(1):30. https:\/\/doi.org\/10.1186\/s41927-025-00479-x PubMed PMID: 40069856; PubMed Central PMCID: PMC11895226.","journal-title":"BMC Rheumatol"},{"issue":"9","key":"663_CR5","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1002\/acr.23143","volume":"69","author":"H Ince-Askan","year":"2017","unstructured":"Ince-Askan H, Hazes JMW, Dolhain RJEM. Identifying clinical factors associated with low disease activity and remission of rheumatoid arthritis during pregnancy. Arthritis Care Res (Hoboken). 2017 Sep;69(9):1297\u2013303. https:\/\/doi.org\/10.1002\/acr.23143 PubMed PMID: 27813290.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"663_CR6","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/art.24003","volume":"59","author":"YA de Man","year":"2008","unstructured":"de Man YA, Dolhain RJEM, van de Geijn FE, Willemsen SP, Hazes JMW. Disease activity of rheumatoid arthritis during pregnancy: Results from a nationwide prospective study. Arthritis Rheumatism. 2008 Sep 15;59(9):1241\u201348. https:\/\/doi.org\/10.1002\/art.24003 PubMed PMID: 18759316.","journal-title":"Arthritis Rheumatism"},{"key":"663_CR7","doi-asserted-by":"publisher","unstructured":"Giles I, Thorne I, Schmidt NS, Reid C, Crossley A, Panca M, et al. The time of equipoise on the use of biological DMARDs in for inflammatory arthritis during pregnancy is finally over: a reappraisal of evidence to optimise pregnancy management. The Lancet Rheumatol. 2024 Aug;6(8):e546\u201359. https:\/\/doi.org\/10.1016\/S2665-9913(24)00097-3 PubMed PMID: 38876126.","DOI":"10.1016\/S2665-9913(24)00097-3"},{"issue":"5","key":"663_CR8","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","volume":"75","author":"G\u00f6testam Skorpen","year":"2016","unstructured":"G\u00f6testam Skorpen, Hoeltzenbein M, Tincani A, Fischer-Betz R, Elefant E, Chambers C, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheumatic Dis. 2016 May;75(5):795\u2013810. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208840 PubMed PMID: 26888948.","journal-title":"Ann Rheumatic Dis"},{"issue":"4","key":"663_CR9","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/art.41191","volume":"72","author":"LR Sammaritano","year":"2020","unstructured":"Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, et al. 2020 American College of Rheumatology Guideline for the management of reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis Rheumatol. 2020 2020 Apr;72(4):529\u201356. https:\/\/doi.org\/10.1002\/art.41191 PubMed PMID: 32090480.","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"663_CR10","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.3899\/jrheum.2025-0048","volume":"52","author":"LK Flatman","year":"2025","unstructured":"Flatman LK, Bernatsky S, B\u00e9rard A, Vinet \u00c9. Patterns of use and discontinuation for Tumor necrosis factor inhibitors in pregnant women: insights from a real-World sample. J Rheumatol. 2025 Nov 1;52(11):1159\u201365. https:\/\/doi.org\/10.3899\/jrheum.2025-0048 PubMed PMID: 40518177.","journal-title":"J Rheumatol"},{"issue":"1","key":"663_CR11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s13075-019-2019-3","volume":"21","author":"Y Meissner","year":"2019","unstructured":"Meissner Y, Strangfeld A, Costedoat-Chalumeau N, F\u00f6rger F, Goll D, Molto A, et al. European Network of pregnancy registers in Rheumatology (EuNeP)\u2014an overview of procedures and data collection. Arthritis Res Ther. 2019 Nov 14;21(1):241. https:\/\/doi.org\/10.1186\/s13075-019-2019-3 PubMed PMID: 31727137; PubMed Central PMCID: PMC6854642.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"663_CR12","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/art.22773","volume":"57","author":"YA de Man","year":"2007","unstructured":"de Man YA, Hazes JMW, van de Geijn FE, Krommenhoek C, Dolhain RJEM. Measuring disease activity and functionality during pregnancy in patients with rheumatoid arthritis. Arthritis Rheumatism. 2007 Jun 15;57(5):716\u201322. https:\/\/doi.org\/10.1002\/art.22773 PubMed PMID: 17530669.","journal-title":"Arthritis Rheumatism"},{"issue":"2","key":"663_CR13","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.autrev.2018.08.008","volume":"18","author":"L Andreoli","year":"2019","unstructured":"Andreoli L, Gerardi MC, Fernandes M, Bortoluzzi A, Bellando-Randone S, Brucato A, et al. Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies. Autoimmun Rev. 2019 Feb;18(2):164\u201376. https:\/\/doi.org\/10.1016\/j.autrev.2018.08.008 PubMed PMID: 30572134.","journal-title":"Autoimmun Rev"},{"issue":"5","key":"663_CR14","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/ar2745","volume":"11","author":"J Fransen","year":"2009","unstructured":"Fransen J, van Riel PLCM. Outcome measures in inflammatory rheumatic diseases. Arthritis Res Ther. 2009;11(5):244. https:\/\/doi.org\/10.1186\/ar2745 PubMed PMID: 19849821; PubMed Central PMCID: PMC2787283.","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"663_CR15","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware","year":"1992","unstructured":"Ware JE, Sherbourne CD. The MOS 36-ltem short-form Health survey (SF-36). Med Care. 1992;30(6):473\u201383. https:\/\/doi.org\/10.1097\/00005650-199206000-00002.","journal-title":"Med Care"},{"issue":"1","key":"663_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12955-022-01992-0","volume":"20","author":"JR Andersen","year":"2022","unstructured":"Andersen JR, Breivik K, Engelund IE, Iversen MM, Kirkeleit J, Norekv\u00e5l TM, et al. Correlated physical and mental health composite scores for the RAND-36 and RAND-12 health surveys: can we keep them simple? Health Qual Life Outcomes. 2022 Dec;20(1):89. https:\/\/doi.org\/10.1186\/s12955-022-01992-0.","journal-title":"Health Qual Life Outcomes"},{"issue":"11","key":"663_CR17","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1002\/art.1780261107","volume":"26","author":"T Pincus","year":"1983","unstructured":"Pincus T, Summey JA, Soraci SA, Wallston KA, Hummon NP. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheumatism. 1983 Nov;26(11):1346\u201353. https:\/\/doi.org\/10.1002\/art.1780261107 PubMed PMID: 6639693.","journal-title":"Arthritis Rheumatism"},{"issue":"4","key":"663_CR18","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1093\/rheumatology\/kei181","volume":"45","author":"T Uhlig","year":"2006","unstructured":"Uhlig T, Haavardsholm EA, Kvien TK. Comparison of the Health Assessment Questionnaire (HAQ) and the modified HAQ (MHAQ) in patients with rheumatoid arthritis. Rheumatology. 2006 Apr 1;45(4):454\u201358. https:\/\/doi.org\/10.1093\/rheumatology\/kei181.","journal-title":"Rheumatology"},{"issue":"11","key":"663_CR19","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1136\/annrheumdis-2012-202281","volume":"72","author":"A van der Maas","year":"2013","unstructured":"van der Maas A, Lie E, Christensen R, Choy E, de Man YA, van Riel P, et al. Construct and criterion validity of several proposed DAS28-based rheumatoid arthritis flare criteria: an OMERACT cohort validation study. Ann Rheumatic Dis. 2013 Nov;72(11):1800\u201305. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202281 PubMed PMID: 23178206.","journal-title":"Ann Rheumatic Dis"},{"issue":"1","key":"663_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/art.1780390105","volume":"39","author":"AM van Gestel","year":"1996","unstructured":"van Gestel AM, Prevoo ML, van\u2019t Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. Development and validation of the European League against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization\/International League against Rheumatism criteria. Arthritis Rheum. 1996 Jan;39(1):34\u201340. https:\/\/doi.org\/10.1002\/art.1780390105 PubMed PMID: 8546736.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"663_CR21","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13075-017-1269-1","volume":"19","author":"van den Brandt S","year":"2017","unstructured":"van den Brandt S, Zbinden A, Baeten D, Villiger PM, \u00d8stensen M, F\u00f6rger, et al. Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients. Arthritis Res Ther. 2017 Mar 20;19(1):64. https:\/\/doi.org\/10.1186\/s13075-017-1269-1 PubMed PMID: 28320445; PubMed Central PMCID: PMC5359860.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"663_CR22","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3390\/life13020359","volume":"13","author":"A Bobirc\u0103","year":"2023","unstructured":"Bobirc\u0103 A, Simionescu AA, Mu\u0219etescu AE, Alexandru C, Bobirc\u0103 F, Bojinc\u0103 M, et al. Outcomes of prospectively followed pregnancies in rheumatoid arthritis: a multicenter study from Romania. Life Basel Switz. 2023 Jan 28;13(2):359. https:\/\/doi.org\/10.3390\/life13020359 PubMed PMID: 36836715; PubMed Central PMCID: PMC9958673.","journal-title":"Life Basel Switz"},{"key":"663_CR23","doi-asserted-by":"crossref","unstructured":"F\u00f6rger F, Vallbracht I, Helmke K, Villiger PM, \u00d8stensen M. Pregnancy mediated improvement of rheumatoid arthritis. In: Swiss med wkly. Vol. 142. ((F\u00f6rger F.) Department of Rheumatology, Clinical Immunology and Allergology, University Hospital and University of Bern, Switzerland.):w13644. Located at: Medline.","DOI":"10.4414\/smw.2012.13644"},{"issue":"6","key":"663_CR24","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1002\/1529-0131(199906)42:6<1219::AID-ANR19>3.0.CO;2-G","volume":"42","author":"JH Barrett","year":"1999","unstructured":"Barrett JH, Brennan P, Fiddler M, Silman AJ. Does rheumatoid arthritis remit during pregnancy and relapse postpartum?: results from a nationwide study in the United Kingdom performed prospectively from late pregnancy. Arthritis Rheumatism. 1999 Jun;42(6):1219\u201327. https:\/\/doi.org\/10.1002\/1529-0131(199906)42:6%26;lt;1219::AID-ANR19%26;gt;3.0.CO;2-G PubMed PMID: 10366115.","journal-title":"Arthritis Rheumatism"},{"key":"663_CR25","doi-asserted-by":"publisher","first-page":"887462","DOI":"10.3389\/fphar.2022.887462","volume":"13","author":"MC Gerardi","year":"2022","unstructured":"Gerardi MC, Crisafulli F, Garc\u00eda-Fernandez A, Lini D, Bazzani C, Cavazzana I, et al. Stopping bDmards at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis. Front Pharmacol. 2022;13:887462. https:\/\/doi.org\/10.3389\/fphar.2022.887462 PubMed PMID: 35991899; PubMed Central PMCID: PMC9384697.","journal-title":"Front Pharmacol"},{"issue":"1","key":"663_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jbspin.2009.11.009","volume":"77","author":"SH Zrour","year":"2010","unstructured":"Zrour SH, Boumiza R, Sakly N, Mannai R, Korbaa W, Younes M, et al. The impact of pregnancy on rheumatoid arthritis outcome: the role of maternofetal HLA class II disparity. Joint Bone Spine. 2010 Jan;77(1):36\u201340. https:\/\/doi.org\/10.1016\/j.jbspin.2009.11.009 PubMed PMID: 20031464.","journal-title":"Joint Bone Spine"},{"issue":"1","key":"663_CR27","doi-asserted-by":"publisher","first-page":"009","DOI":"10.1055\/s-0033-1333666","volume":"31","author":"ES Langen","year":"2013","unstructured":"Langen ES, Chakravarty EF, Liaquat M, El-Sayed YY, Druzin ML. High rate of preterm birth in pregnancies complicated by rheumatoid arthritis. Amer J Perinatol. 2013;31(1):009\u2013014. Located at: Embase. https:\/\/doi.org\/10.1055\/s-0033-1333666.","journal-title":"Amer J Perinatol"},{"issue":"8","key":"663_CR28","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1136\/annrheumdis-2018-212946","volume":"77","author":"A Bondt","year":"2018","unstructured":"Bondt A, Hafkenscheid L, Falck D, Kuijper TM, Rombouts Y, Hazes JMW, et al. ACPA IgG galactosylation associates with disease activity in pregnant patients with rheumatoid arthritis. Ann Rheumatic Dis. 2018 Aug;77(8):1130\u201336. https:\/\/doi.org\/10.1136\/annrheumdis-2018-212946 PubMed PMID: 29615411.","journal-title":"Ann Rheumatic Dis"},{"issue":"2","key":"663_CR29","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1136\/ard.2008.104331","volume":"69","author":"YA de Man","year":"2010","unstructured":"de Man YA, Bakker-Jonges LE, Goorbergh CMD-VD, Tillemans SPR, Hooijkaas H, Hazes JMW, et al. Women with rheumatoid arthritis negative for anti-cyclic citrullinated peptide and rheumatoid factor are more likely to improve during pregnancy, whereas in autoantibody-positive women autoantibody levels are not influenced by pregnancy. Ann Rheumatic Dis. 2010 Feb;69(2):420\u201323. https:\/\/doi.org\/10.1136\/ard.2008.104331 PubMed PMID: 19282308.","journal-title":"Ann Rheumatic Dis"},{"key":"663_CR30","doi-asserted-by":"publisher","unstructured":"Smeele HTW, Dolhain RJEM. Current perspectives on fertility, pregnancy and childbirth in patients with rheumatoid arthritis. Semin arthritis Rheum. 1;Advances in Targeted Therapies: Proceedings of the 2019 Meeting49(3. 2019 Dec): S32\u20135. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.09.010 Supplement.","DOI":"10.1016\/j.semarthrit.2019.09.010"},{"issue":"6","key":"663_CR31","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.ard.2025.02.023","volume":"84","author":"L R\u00fcegg","year":"2025","unstructured":"R\u00fcegg L, Pluma A, Hamroun S, Cecchi I, Perez-Garcia LF, Anderson PO, et al. EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update. Ann Rheumatic Dis. 2025 Jun 1;84(6):910\u201326. https:\/\/doi.org\/10.1016\/j.ard.2025.02.023 PubMed PMID: 40287311.","journal-title":"Ann Rheumatic Dis"},{"issue":"5","key":"663_CR32","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/03009742.2024.2303832","volume":"53","author":"L Flatman","year":"2024","unstructured":"Flatman L, Malham\u00e9 I, Colmegna I, B\u00e9rard A, Bernatsky S, Vinet \u00c9. Tumour necrosis factor inhibitors and serious infections in reproductive-age women and their offspring: a narrative review. Scand J Rheumatol. 2024 Sep 1;53(5):295\u2013306. Located at: 179685732. https:\/\/doi.org\/10.1080\/03009742.2024.2303832.","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"663_CR33","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/acr.25045","volume":"75","author":"AR Bass","year":"2023","unstructured":"Bass AR, Chakravarty E, Akl EA, Bingham CO, Calabrese L, Cappelli LC, et al. 2022 American college of rheumatology guideline for vaccinations in patients with rheumatic and musculoskeletal diseases. Arthritis Care Res (Hoboken). 2023;75(3):449\u201364. Located at: Embase. https:\/\/doi.org\/10.1002\/acr.25045.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"12","key":"663_CR34","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.3899\/jrheum.201439","volume":"48","author":"S Rampes","year":"2021","unstructured":"Rampes S, Patel V, Bosworth A, Jacklin C, Nagra D, Yates M, et al. Systematic review and Metaanalysis of the reproducibility of patient self-reported joint counts in rheumatoid arthritis. J Rheumatol. 2021 Dec;48(12):1784\u201392. https:\/\/doi.org\/10.3899\/jrheum.201439 PubMed PMID: 33993117.","journal-title":"J Rheumatol"}],"container-title":["BMC Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-026-00663-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-026-00663-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-026-00663-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T23:23:15Z","timestamp":1786058595000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41927-026-00663-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["663"],"URL":"https:\/\/doi.org\/10.1186\/s41927-026-00663-7","relation":{},"ISSN":["2520-1026"],"issn-type":[{"value":"2520-1026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"10 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study involves human participants and was performed in accordance with the Declaration of Helsinki and its amendments. The RevNatus register was approved by the Regional Committee for Medical and Health Research Ethics (REK) Mid Norway in 2006. All women included in RevNatus have signed a written informed consent. The current study was approved by REK Mid Norway in 2018 (REK 2018\/2147)","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"63"}}